Expression of human vasopressin and oxytocin receptors in Escherichia coli

被引:0
作者
Mouillac, B
Sen, T
Durroux, T
Gaibelet, G
Barberis, C
机构
[1] INSERM U469, F-34094 Montpellier 5, France
[2] AVIDIS SA, Biopole Clermont Limagne, F-63360 St Beauzire, France
来源
VASOPRESSIN AND OXYTOCIN: FROM GENES TO CLINICAL APPLICATIONS | 2002年 / 139卷
关键词
G protein-coupled receptor; Escherichia coli; heterologous expression; inclusion body; receptor purification;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to produce large amounts of human vasopressin and oxytocin receptors compatible with direct structural biology approaches such as X-ray crystallography, NMR or mass spectrometry, we have expressed these neurohypophysial hormone receptors in Escherichia coli. To facilitate the level of expression, the coding sequence for the V(1a), vasopressin receptor and the oxytocin receptor were first optimized for bacterial expression. The resulting 'bacterial receptor cDNAs' were then subcloned into pET/T7-driven prokaryotic expression vectors. Different constructs have been prepared: each cDNA was incorporated alone or in fusion with a T7 tag sequence or a glutathione-S-transferase tag sequence at the N-terminus end. Moreover, a 6 x His tag sequence has been added at the C-terminus end for one-step purification of the receptors. Screening of BL21(DE3) and BL21(DE3)pLysS bacterial strains transformed with the different constructions was achieved by Coomassie blue-stained SDS-polyacrylamide gels and by 6 x His antibody Western blotting. Several clones were selected for purification of the receptors. Expression levels of the receptors are no", encouraging and will be optimized for further structural and functional studies. Moreover, at the same time, the construction of the bacterial-optimized sequence of the V(2) vasopressin receptor and its expression will be performed.
引用
收藏
页码:163 / 177
页数:15
相关论文
共 40 条
  • [1] INVIVO HALF-LIFE OF A PROTEIN IS A FUNCTION OF ITS AMINO-TERMINAL RESIDUE
    BACHMAIR, A
    FINLEY, D
    VARSHAVSKY, A
    [J]. SCIENCE, 1986, 234 (4773) : 179 - 186
  • [2] Structural bases of vasopressin/oxytocin receptor function
    Barberis, C
    Mouillac, B
    Durroux, T
    [J]. JOURNAL OF ENDOCRINOLOGY, 1998, 156 (02) : 223 - 229
  • [3] Molecular pharmacology of AVP and OT receptors and therapeutic potential
    Barberis, C
    Morin, D
    Durroux, T
    Mouillac, B
    Guillon, G
    Seyer, R
    Hibert, M
    Tribollet, E
    Manning, M
    [J]. DRUG NEWS & PERSPECTIVES, 1999, 12 (05) : 279 - 292
  • [4] Molecular tinkering of G protein-coupled receptors: an evolutionary success
    Bockaert, J
    Pin, JP
    [J]. EMBO JOURNAL, 1999, 18 (07) : 1723 - 1729
  • [5] Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist -: Comparison with the human V1a vasopressin receptor
    Breton, C
    Chellil, H
    Kabbaj-Benmansour, M
    Carnazzi, E
    Seyer, R
    Phalipou, S
    Morin, D
    Durroux, T
    Zingg, H
    Barberis, C
    Mouillac, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) : 26931 - 26941
  • [6] TYR115 IS THE KEY RESIDUE FOR DETERMINING AGONIST SELECTIVITY IN THE V1A VASOPRESSIN RECEPTOR
    CHINI, B
    MOUILLAC, B
    ALA, Y
    BALESTRE, MN
    TRUMPPKALLMEYER, S
    HOFLACK, J
    ELANDS, J
    HIBERT, M
    MANNING, M
    JARD, S
    BARBERIS, C
    [J]. EMBO JOURNAL, 1995, 14 (10) : 2176 - 2182
  • [7] Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding
    Cotte, N
    Balestre, MN
    Aumelas, A
    Mahé, E
    Phalipou, S
    Morin, D
    Hibert, M
    Manning, M
    Durroux, T
    Barberis, C
    Mouillac, B
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (13): : 4253 - 4263
  • [8] Identification of residues responsible for the selective binding of peptide antagonists and agonists in the V2 vasopressin receptor
    Cotte, N
    Balestre, MN
    Phalipou, S
    Hibert, M
    Manning, M
    Barberis, C
    Mouillac, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) : 29462 - 29468
  • [9] DILLON PJ, 1993, PCR PROTOCOLS CURREN, V15, P263
  • [10] Activation mechanism of human oxytocin receptor: A combined study of experimental and computer-simulated mutagenesis
    Fanelli, F
    Barbier, P
    Zanchetta, D
    De Benedetti, PG
    Chini, B
    [J]. MOLECULAR PHARMACOLOGY, 1999, 56 (01) : 214 - 225